Dr. Hanan Goldberg

Dr. Hanan Goldberg
Dr. Goldberg brings with him many years of experience with an extensive number of awards and over 85 publications in high ranking urology and urological oncology journals. He continues to be actively involved in clinical and research work, promoting patient urologic care. He is an active member in many international professional urological societies, and is a reviewer for some of the most prestigious urological journals. His research focuses on urological cancer and specifically prostate cancer prevention and treatment. Dr. Goldberg is an assistant professor at SUNY Upstate Medical University in Syracuse, New York, and his areas of expertise include prostate cancer, kidney cancer, bladder cancer, upper tract urothelial carcinoma, testicular cancer and disorders of the adrenal. Dr. Goldberg also treats common urological diseases including benign prostatic hyperplasia (BPH), urinary stone disease, erectile dysfunction, infertility, hydrocele and incontinence. Dr. Goldberg is located at the Faxton Campus, 1676 Sunset Avenue, Utica, New York, and can be reached at 315-624-5252.

Languages Spoken:

English, Hebrew

Medical School:

Medical School Hebrew University, Jerusalem, Israel


Department Of Urology, Rabin Medical Center


Princess Margaret Cancer center, University of Toronto, SUO Uro-oncology fellowship

All surgical treatments have inherent and associated side effects. Individual’s outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience. The most common side effects are mild and transient and may include mild pain or difficulty when urinating, discomfort in the pelvis, blood in the urine, inability to empty the bladder or a frequent and/or urgent need to urinate, and bladder or urinary tract infection. Other risks include ejaculatory dysfunction and a low risk of injury to the urethra or rectum where the devices gain access to the body for treatment. Further, there may be other risks as in other urological surgery, such as anesthesia risk or the risk of infection, including the potential transmission of blood borne pathogens. For more information about potential side effects and risks associated with Aquablation therapy for Benign Prostatic Hyperplasia (BPH) treatment, speak with your urologist or surgeon. Prior to using our products, please review the Instructions for Use, Operator’s Manual or User Manual, as applicable, and any accompanying documentation for a complete listing of indications, contraindications, warnings, precautions and potential adverse events. No claim is made that the AquaBeam Robotic System will cure any medical condition, or entirely eliminate the diseased entity. Repeated treatment or alternative therapies may sometimes be required.

Rx Only